Prostate cancer immunotherapy: where are we and where are we going?
作者： Marco A. De Velasco , Hirotsugu Uemura
DOI: 10.1097/MOU.0000000000000462
关键词:
摘要: Purpose of reviewIn this review, we present the progress and current landscape for prostate cancer immunotherapy overview recent scientific findings that shed novel insights into immunoresistance discuss potential therapeutic strategies.Recent findingsProstate immunogenicity is hamper
sci-hub.se 参考文章(113)
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard, Himisha Beltran, Wassim Abida, Robert K Bradley, Jake Vinson, Xuhong Cao, Pankaj Vats, Lakshmi P Kunju, Maha Hussain, Felix Y Feng, Scott A Tomlins, Kathleen A Cooney, David C Smith, Christine Brennan, Javed Siddiqui, Rohit Mehra, Yu Chen, Dana E Rathkopf, Michael J Morris, Stephen B Solomon, Jeremy C Durack, Victor E Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T Lis, Michaela Bowden, Stephen P Balk, Glenn Gaviola, Carrie Sougnez, Manaswi Gupta, Y Yu Evan, Elahe A Mostaghel, Heather H Cheng, Hyojeong Mulcahy, Lawrence D True, Stephen R Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquin Mateo, Raquel Perez-Lopez, Francesca Demichelis, Brian D Robinson, Marc Schiffman, David M Nanus, Scott T Tagawa, Alexandros Sigaras, Kenneth W Eng, Olivier Elemento, Andrea Sboner, Elisabeth I Heath, Howard I Scher, Kenneth J Pienta, Philip Kantoff, Johann S De Bono, Mark A Rubin, Peter S Nelson, Levi A Garraway, Charles L Sawyers, Arul M Chinnaiyan, None, Integrative clinical genomics of advanced prostate cancer Cell. ,vol. 161, pp. 1215- 1228 ,(2015) , 10.1016/J.CELL.2015.05.001
Jennifer L. Bishop, Alexander Sio, Arkhjamil Angeles, Morgan E. Roberts, Arun A. Azad, Kim N. Chi, Amina Zoubeidi, PD-L1 is highly expressed in Enzalutamide resistant prostate cancer Oncotarget. ,vol. 6, pp. 234- 242 ,(2015) , 10.18632/ONCOTARGET.2703
Michele W.L. Teng, Shin Foong Ngiow, Antoni Ribas, Mark J. Smyth, Classifying Cancers Based on T-cell Infiltration and PD-L1 Cancer Research. ,vol. 75, pp. 2139- 2145 ,(2015) , 10.1158/0008-5472.CAN-15-0255
Haydn T. Kissick, Martin G. Sanda, Laura K. Dunn, Kathryn L. Pellegrini, Seung T. On, Jonathan K. Noel, Mohamed S. Arredouani, Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, pp. 9887- 9892 ,(2014) , 10.1073/PNAS.1402468111
Kathleen Ebelt, Gregor Babaryka, Bernhard Frankenberger, Christian G. Stief, Wolfgang Eisenmenger, Thomas Kirchner, Dolores J. Schendel, Elfriede Noessner, Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters European Journal of Cancer. ,vol. 45, pp. 1664- 1672 ,(2009) , 10.1016/J.EJCA.2009.02.015
Massimo Ammirante, Jun-Li Luo, Sergei Grivennikov, Sergei Nedospasov, Michael Karin, B-cell-derived lymphotoxin promotes castration-resistant prostate cancer Nature. ,vol. 464, pp. 302- 305 ,(2010) , 10.1038/NATURE08782
Eugene D Kwon, Charles G Drake, Howard I Scher, Karim Fizazi, Alberto Bossi, Alfons J M van den Eertwegh, Michael Krainer, Nadine Houede, Ricardo Santos, Hakim Mahammedi, Siobhan Ng, Michele Maio, Fabio A Franke, Santhanam Sundar, Neeraj Agarwal, Andries M Bergman, Tudor E Ciuleanu, Ernesto Korbenfeld, Lisa Sengeløv, Steinbjorn Hansen, Christopher Logothetis, Tomasz M Beer, M Brent McHenry, Paul Gagnier, David Liu, Winald R Gerritsen, Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial Lancet Oncology. ,vol. 15, pp. 700- 712 ,(2014) , 10.1016/S1470-2045(14)70189-5
Timothy J. Roth, Yuri Sheinin, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, Brant A. Inman, Amy E. Krambeck, Maureen E. Mckenney, R. Jeffrey Karnes, Michael L. Blute, John C. Cheville, Thomas J. Sebo, Eugene D. Kwon, B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy Cancer Research. ,vol. 67, pp. 7893- 7900 ,(2007) , 10.1158/0008-5472.CAN-07-1068
Kenneth A. Iczkowski, Kathleen C. Torkko, R. Storey Wilson, M. Scott Lucia, David G. Bostwick, Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides Human Pathology. ,vol. 45, pp. 54- 58 ,(2014) , 10.1016/J.HUMPATH.2013.07.041
Luana Calabrò, Riccardo Danielli, Luca Sigalotti, Michele Maio, Clinical Studies With Anti–CTLA-4 Antibodies in Non-melanoma Indications Seminars in Oncology. ,vol. 37, pp. 460- 467 ,(2010) , 10.1053/J.SEMINONCOL.2010.09.006